Autoantibody targets in vaccine-associated narcolepsy

Autoimmunity

Volumn 49, Issue 6, 2016, Pages 421-433

  Häggmark Månberg, Anna ^a   Zandian, Arash ^a   Forsström, Björn ^a   Khademi, Mohsen ^b   Lima Bomfim, Izaura ^b   Hellström, Cecilia ^a   Arnheim Dahlström, Lisen ^b   Hallböök, Tove ^c   Darin, Niklas ^c   Lundberg, Ingrid E ^d   Uhlén, Mathias ^a   Partinen, Markku ^e,f   Schwenk, Jochen M ^a   Olsson, Tomas ^b   Nilsson, Peter ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Vitalmed Research Centre   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

autoantibody; Narcolepsy; protein microarray; serum; vaccine associated

Indexed keywords

5' NUCLEOTIDASE; 5' NUCLEOTIDASE CYTOSOLIC IA; AUTOANTIBODY; AUTOANTIGEN; CYCLIN DEPENDENT KINASE 1; GLUTAMINASE; IMMUNOGLOBULIN G; METHYLTRANSFERASE; METHYLTRANSFERASE LIKE 22; UNCLASSIFIED DRUG; EPITOPE; NT5C1A PROTEIN, HUMAN; VACCINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SEQUENCE ANALYSIS; SUSPENSION; BLOOD; CASE CONTROL STUDY; EPITOPE MAPPING; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

5'-NUCLEOTIDASE; ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CASE-CONTROL STUDIES; CHILD; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NARCOLEPSY; VACCINES; YOUNG ADULT;

EID: 84969988196     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916934.2016.1183655     Document Type: Article

References (49)

1. Kornum, B. R., J., Faraco, E., Mignot. 2011. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr. Opin. Neurobiol. 21:897–903
2. Kumar, S., H., Sagili. 2014. Etiopathogenesis and neurobiology of narcolepsy:a review. J. Clin. Diagn. Res. 8:190–195
3. Mignot, E., R., Hayduk, J., Black, et al. 1997. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 20:1012–1020
4. Faraco, J., L., Lin, B. R., Kornum, et al. 2013. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Gen. 9:e1003270
5. Hallmayer, J., J., Faraco, L., Lin, et al. 2009. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Gen. 41:708–711
6. Kornum, B. R., M., Kawashima, J., Faraco, et al. 2011. Common variants in P2RY11 are associated with narcolepsy. Nat. Gen. 43:66–71
7. Nohynek, H., J., Jokinen, M., Partinen, et al. 2012. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One. 7:e33536
8. O'Flanagan, D., A. S., Barret, M., Foley, et al. 2014. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009–December 2010. Euro surveillance:bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 19:15–25
9. Widgren, K., M., Magnusson, P., Hagstam, et al. 2013. Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro surveillance:bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 18:20447
10. Wijnans, L., C., Lecomte, C., de Vries, et al. 2013. The incidence of narcolepsy in Europe:before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine. 31:1246–1254
11. Persson, I., F., Granath, J., Askling, et al. 2014. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix:a population- and registry-based cohort study with over 2 years of follow-up. J. Int. Med. 275:172–190
12. The Swedish Medical Products Agency (Läkemedelsverket) - The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix. Available at:https://lakemedelsverket.se/english/All-news/NYHETER-2010/The-MPA-investigates-reports-of-narcolepsy-in-patients-vaccinated-with-Pandemrix/; 2010
13. Bardage, C., I., Persson, A., Ortqvist, et al. 2011. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine:population based cohort study in Stockholm, Sweden. BMJ. 343:d5956
14. Heier, M. S., K. M., Gautvik, E., Wannag, et al. 2013. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 14:867–871
15. Dauvilliers, Y., I., Arnulf, M., Lecendreux, et al. 2013. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain. 136:2486–2496
16. Szakacs, A., N., Darin, T., Hallbook. 2013. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology. 80:1315–1321
17. Miller, E., N., Andrews, L., Stellitano, et al. 2013. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine:retrospective analysis. BMJ. 346:f794
18. Partinen, M., O., Saarenpaa-Heikkila, I., Ilveskoski, et al. 2012. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 7:e33723
19. Blank, M., O., Barzilai, Y., Shoenfeld. Molecular mimicry and auto-immunity. 2007. Clin. Rev. Allergy Immunol. 32:111–118
20. Mahlios, J., A. K., De la Herran-Arita, E., Mignot. 2013. The autoimmune basis of narcolepsy. Curr. Opin. Neurobiol. 23:767–773
21. Ahmed, S. S., W., Volkmuth, J., Duca, et al. 2015. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci. Transl. Med. 7:294ra105
22. Cvetkovic-Lopes, V., L., Bayer, S., Dorsaz, et al. 2010. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120:713–719
23. Lind, A., A., Ramelius, T., Olsson, et al. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009–2010. J. Autoimmun. 2014:1–8
24. Katzav, A., M. T., Arango, S., Kivity, et al. 2013. Passive transfer of narcolepsy:anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J. Autoimmun. 45:24–30
25. Bergman, P., C., Adori, S., Vas, et al. 2014. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl. Acad. Sci. USA. 111:E3735–E3744
26. Smith, A. J., M. W., Jackson, P., Neufing, et al. 2004. A functional autoantibody in narcolepsy. Lancet. 364:2122–2124
27. Ayoglu, B., A., Haggmark, M., Khademi, et al. 2013. Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol. Cell. Proteomics. 12:2657–2672
28. Feltelius, N., I., Persson, Ahlqvist-Rastad J., et al. 2015. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009–2010 Pandemrix vaccination programme in Sweden. J. Int. Med. 278:335–353
29. Bohan, A., J. B., Peter. 1975. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292:344–347
30. Griggs, R. C., V., Askanas, S., DiMauro, et al. 1995. Inclusion body myositis and myopathies. Ann. Neurol. 38:705–713
31. Agaton, C., R., Falk, I., Hoiden Guthenberg, et al. 2004. Selective enrichment of monospecific polyclonal antibodies for antibody-based proteomics efforts. J. Chromatogr. A. 1043:33–40
32. Berglund, L., E., Bjorling, K., Jonasson, et al. 2008. A whole-genome bioinformatics approach to selection of antigens for systematic antibody generation. Proteomics. 8:2832–2839
33. Häggmark, A., C., Hamsten, E., Wiklundh, et al. 2015. Proteomic profiling reveals autoimmune targets in sarcoidosis. Am. J. Respir. Crit. Care. Med. 191:574–583
34. Forsstrom, B., B. B., Axnas, K. P., Stengele, et al. 2014. Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol. Cell. Proteomics. 13:1585–1597
35. Henjes, F., L., Lourido, C., Ruiz-Romero, et al. 2014. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. J. Proteome Res. 13:5218–5229
36. Altschul, S. F., T. L., Madden, A. A., Schaffer, et al. 1997. Gapped BLAST and PSI-BLAST:a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402
37. Kringelum, J. V., M., Nielsen, S. B., Padkjaer, O., Lund. 2013. Structural analysis of B-cell epitopes in antibody:protein complexes. Mol. Immunol. 53:24–34
38. Cloutier, P., M., Lavallee-Adam, D., Faubert, et al. 2013. A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Gen. 9:e1003210
39. Despras, E., L., Miccoli, C., Creminon, et al. 2003. Depletion of KIN17, a human DNA replication protein, increases the radiosensitivity of RKO cells. Radiat. Res. 159:748–758
40. Borowiec, A., K., Lechward, K., Tkacz-Stachowska, A. C., Skladanowski. 2006. Adenosine as a metabolic regulator of tissue function:production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim. Pol. 53:269–278
41. Larman, H. B., M., Salajegheh, R., Nazareno, et al. 2013. Cytosolic 5′-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann. Neurol. 73:408–418
42. Gass, N., H. M., Ollila, S., Utge, et al. 2010. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J. Affect. Disord. 126:134–139
43. Thakkar, M. M., S. C., Engemann, K. M., Walsh, P. K., Sahota. 2008. Adenosine and the homeostatic control of sleep:effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience. 153:875–880
44. Schwartz, M., I., Shaked, J., Fisher, et al. 2003. Protective autoimmunity against the enemy within:fighting glutamate toxicity. Trends Neurosci. 26:297–302
45. Piani, D., K., Frei, K. Q., Do, et al. 1991. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133:159–162
46. Alexopoulos, H., E. I., Kampylafka, I., Chatzi, et al. 2013. Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 260:117–120
47. Belogurov, A. A., Jr., I. N., Kurkova, A., Friboulet, et al. 2008. Recognition and degradation of myelin basic protein peptides by serum autoantibodies:novel biomarker for multiple sclerosis. J. Immunol. 180:1258–1267
48. Tanaka, S., Y., Honda, Y., Inoue, M., Honda. 2006. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy:anti-Hcrt system antibody in narcolepsy. Sleep. 29:633–638
49. Haggmark, A., J. M., Schwenk, P., Nilsson. 2016. Neuroproteomic profiling of human body fluids. Proteomics Clin. Appl. 10:485–502